Variant report

Variant	esv3412851
Chromosome Location	chr8:39821844-39840828
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:169)
CpG islands
(count:305)
Chromatin interactive
region (count:5)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:169 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr8:39835869-39836314	K562	blood:	n/a	n/a
2	ATF2	chr8:39823727-39824155	GM12878	blood:	n/a	n/a
3	ATF2	chr8:39821596-39822023	GM12878	blood:	n/a	n/a
4	BATF	chr8:39821625-39821990	GM12878	blood:	n/a	n/a
5	BATF	chr8:39821653-39821969	GM12878	blood:	n/a	n/a
6	BATF	chr8:39827320-39827607	GM12878	blood:	n/a	n/a
7	BCL11A	chr8:39823799-39824076	GM12878	blood:	n/a	n/a
8	BCL11A	chr8:39823769-39824045	GM12878	blood:	n/a	n/a
9	BCL11A	chr8:39821644-39822010	GM12878	blood:	n/a	n/a
10	BCL11A	chr8:39821650-39821912	GM12878	blood:	n/a	n/a
11	BHLHE40	chr8:39823795-39824178	GM12878	blood:	n/a	n/a
12	BHLHE40	chr8:39835983-39836274	K562	blood:	n/a	n/a
13	BHLHE40	chr8:39820800-39821985	GM12878	blood:	n/a	n/a
14	CBX3	chr8:39835868-39836337	K562	blood:	n/a	n/a
15	CCNT2	chr8:39835846-39836313	K562	blood:	n/a	n/a
16	CEBPB	chr8:39829345-39829349	K562	blood:	n/a	n/a
17	CEBPB	chr8:39837309-39837529	K562	blood:	n/a	chr8:39837363-39837374 chr8:39837394-39837405
18	CEBPB	chr8:39837323-39837505	HepG2	liver:	n/a	chr8:39837363-39837374 chr8:39837394-39837405
19	CEBPB	chr8:39840458-39840618	HepG2	liver:	n/a	n/a
20	CEBPB	chr8:39829630-39829861	K562	blood:	n/a	chr8:39829677-39829688
21	CEBPB	chr8:39835877-39836353	K562	blood:	n/a	n/a
22	CEBPB	chr8:39825588-39825795	HepG2	liver:	n/a	chr8:39825717-39825728
23	CEBPB	chr8:39829349-39829875	HepG2	liver:	n/a	chr8:39829677-39829688
24	CEBPB	chr8:39821202-39821921	Hela-S3	cervix:	n/a	n/a
25	CEBPD	chr8:39835909-39836349	K562	blood:	n/a	n/a
26	CEBPD	chr8:39835827-39836447	K562	blood:	n/a	n/a
27	CHD1	chr8:39821998-39822006	GM12878	blood:	n/a	n/a
28	CHD2	chr8:39821655-39821971	GM12878	blood:	n/a	n/a
29	CHD2	chr8:39835890-39836296	K562	blood:	n/a	n/a
30	CREB1	chr8:39835687-39836401	K562	blood:	n/a	n/a
31	CREB1	chr8:39835730-39836342	K562	blood:	n/a	n/a
32	CTCF	chr8:39823920-39824070	GM06990	blood:	n/a	n/a
33	CTCF	chr8:39823920-39824070	GM12864	blood:	n/a	n/a
34	CTCF	chr8:39822742-39822773	GM13976	blood:	n/a	n/a
35	CTCF	chr8:39823900-39824050	GM12871	blood:	n/a	n/a
36	CTCF	chr8:39823920-39824070	GM12865	blood:	n/a	n/a
37	CTCF	chr8:39823937-39824137	HUVEC	blood vessel:	n/a	n/a
38	CTCF	chr8:39823900-39824050	GM12872	blood:	n/a	n/a
39	CTCF	chr8:39823815-39823904	GM13976	blood:	n/a	n/a
40	CTCF	chr8:39823820-39824110	GM06990	blood:	n/a	n/a
41	CTCF	chr8:39823940-39824090	GM12873	blood:	n/a	n/a
42	CTCF	chr8:39824000-39824150	GM12873	blood:	n/a	n/a
43	CTCF	chr8:39823831-39823881	LNCaP	prostate:	n/a	n/a
44	CTCF	chr8:39823960-39824110	GM12874	blood:	n/a	n/a
45	CTCF	chr8:39823957-39824131	GM12878	blood:	n/a	n/a
46	CTCF	chr8:39835360-39835510	NHDF-neo	bronchial:	n/a	n/a
47	CTCF	chr8:39823960-39824110	GM12878	blood:	n/a	n/a
48	CTCF	chr8:39823820-39824228	GM12878	blood:	n/a	n/a
49	CTCF	chr8:39824000-39824150	HCPEpiC	choroid plexus:	n/a	n/a
50	CTCF	chr8:39824040-39824190	GM12871	blood:	n/a	n/a

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:39835944-39835994	NHBE	bronchial:	n/a
2	chr8:39835730-39835780	GM06990	blood:	n/a
3	chr8:39836064-39836114	HUVEC	blood vessel:	n/a
4	chr8:39835944-39835994	HepG2	liver:	n/a
5	chr8:39836064-39836114	AG09309	skin:	n/a
6	chr8:39835944-39835994	SAEC	small airway:	n/a
7	chr8:39835697-39835747	HCPEpiC	choroid plexus:	n/a
8	chr8:39836064-39836114	HCF	heart:	n/a
9	chr8:39835944-39835994	LNCaP	prostate:	n/a
10	chr8:39836007-39836057	LNCaP	prostate:	n/a
11	chr8:39835730-39835780	GM12892	blood:	n/a
12	chr8:39835944-39835994	PFSK-1	brain:	n/a
13	chr8:39835730-39835780	T-47D	breast:	n/a
14	chr8:39835697-39835747	SK-N-MC	brain:	n/a
15	chr8:39835730-39835780	HCPEpiC	choroid plexus:	n/a
16	chr8:39835730-39835780	U87	brain:	n/a
17	chr8:39835944-39835994	A549	lung:	n/a
18	chr8:39835730-39835780	HL-60	blood:	n/a
19	chr8:39835944-39835994	Hela-S3	cervix:	n/a
20	chr8:39835697-39835747	U87	brain:	n/a
21	chr8:39835944-39835994	ProgFib	skin:	n/a
22	chr8:39835697-39835747	ECC-1	luminal epithelium:	n/a
23	chr8:39836064-39836114	HL-60	blood:	n/a
24	chr8:39835697-39835747	HIPEpiC	eye:	n/a
25	chr8:39835944-39835994	Caco-2	colon:	n/a
26	chr8:39835730-39835780	ovcar-3	ovarian:	n/a
27	chr8:39836064-39836114	GM12891	blood:	n/a
28	chr8:39836064-39836114	H1-hESC	embryonic stem cell:	embryo
29	chr8:39835730-39835780	NHBE	bronchial:	n/a
30	chr8:39835697-39835747	HCT-116	colon:	n/a
31	chr8:39836007-39836057	AG09309	skin:	n/a
32	chr8:39835944-39835994	Jurkat	blood:	n/a
33	chr8:39835697-39835747	HAEpiC	amniotic membrane:	n/a
34	chr8:39835944-39835994	AG04450	lung:	fetal
35	chr8:39836007-39836057	HCM	heart:	n/a
36	chr8:39836007-39836057	A549	lung:	n/a
37	chr8:39835730-39835780	HCF	heart:	n/a
38	chr8:39836064-39836114	GM12892	blood:	n/a
39	chr8:39835697-39835747	GM12892	blood:	n/a
40	chr8:39835697-39835747	IMR90	lung:	fetal
41	chr8:39835697-39835747	NHBE	bronchial:	n/a
42	chr8:39836007-39836057	PFSK-1	brain:	n/a
43	chr8:39835730-39835780	HCM	heart:	n/a
44	chr8:39835730-39835780	IMR90	lung:	fetal
45	chr8:39836007-39836057	GM19239	blood:	n/a
46	chr8:39835944-39835994	PrEC	prostate:	n/a
47	chr8:39836007-39836057	GM12892	blood:	n/a
48	chr8:39835697-39835747	HCF	heart:	n/a
49	chr8:39835944-39835994	CMK	blood:	n/a
50	chr8:39835944-39835994	GM12891	blood:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:39835248..39839465-chr8:39839915..39843090,3	K562	blood:
2	chr8:39783610..39785515-chr8:39835256..39838149,2	K562	blood:
3	chr8:39835248..39839465-chr8:39839915..39843090,3	K562	blood:
4	chr8:39829552..39832738-chr8:39834511..39836404,3	K562	blood:
5	chr8:39829552..39832738-chr8:39834511..39836404,3	K562	blood:

No data

Variant related genes	Relation type
IDO2	TF binding region
IDO2	CpG island

Extended variants
information (count: 645 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:645 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2729461	chr8:39821879-39821880	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs6983759	chr8:39821915-39821916	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs571635510	chr8:39821921-39821922	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs191563304	chr8:39821923-39821924	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs2543054	chr8:39821948-39821949	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs573700560	chr8:39821952-39821953	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs536506564	chr8:39821966-39821967	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs555241040	chr8:39822030-39822031	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs143609527	chr8:39822032-39822033	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs538294982	chr8:39822110-39822111	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs2729462	chr8:39822139-39822140	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs2729463	chr8:39822167-39822168	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
13	rs62513780	chr8:39822172-39822173	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs183855568	chr8:39822202-39822203	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs188574380	chr8:39822287-39822288	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs181391292	chr8:39822302-39822303	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs560151450	chr8:39822313-39822314	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs62513781	chr8:39822319-39822320	Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs549048211	chr8:39822330-39822331	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs147751331	chr8:39822335-39822336	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs2729466	chr8:39822359-39822360	Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs551253467	chr8:39822367-39822368	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs571441736	chr8:39822374-39822375	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs546042362	chr8:39822403-39822404	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs547493143	chr8:39822409-39822410	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs142592108	chr8:39822459-39822460	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs186588041	chr8:39822460-39822461	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs35652511	chr8:39822468-39822469	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs146382040	chr8:39822509-39822510	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs576643659	chr8:39822532-39822533	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs539332774	chr8:39822548-39822549	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs558854555	chr8:39822572-39822573	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs572689837	chr8:39822579-39822580	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs190411706	chr8:39822590-39822591	Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs2052379	chr8:39822630-39822631	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs2052378	chr8:39822638-39822639	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
37	rs542629021	chr8:39822647-39822648	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs562520804	chr8:39822663-39822664	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs539849549	chr8:39822764-39822765	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs111612687	chr8:39822772-39822773	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs182079899	chr8:39822779-39822780	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs148296606	chr8:39822803-39822804	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs140524934	chr8:39822805-39822806	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs2052377	chr8:39822850-39822851	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs567400446	chr8:39822897-39822898	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs2111741	chr8:39822908-39822909	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs549870586	chr8:39822940-39822941	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs570051624	chr8:39822955-39822956	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs2340951	chr8:39822964-39822965	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
50	rs563770982	chr8:39823032-39823033	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Prostate cancer	16573809	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Prostate cancer	21965145	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Colorectal cancer	16272173	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Seminomas	18059402	CNVD
Lung cancer	18438408	CNVD
Myxofibrosarcoma	16751306	CNVD
Immune disease	21572526	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Kallmann Syndrome 2	22470819	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Pancreatic cancer	21811587	CNVD
Multiple myeloma	16461302	CNVD
Developmental delay	21373258	CNVD
Thyroid cancer	19087340	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	17603634	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Disorders of sex development	21048976	CNVD
Testicular cancer	18059402	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hepatocellular carcinoma	16750200	CNVD
Bladder cancer	19088036	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Breast cancer	17001308	CNVD
Breast cancer	17157792	CNVD
Cancer	17001308	CNVD
Cancer	18840272	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Chordoma	18071362	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Breast cancer	16608533	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21785460	CNVD
abnormal development	18461090	CNVD
Rhabdomyosarcoma	16790082	CNVD
Prostate cancer	18632612	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21858162	CNVD
Cancer	20164920	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Medulloblastoma	19270706	CNVD
Cancer	20164919	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:108 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:39818200-39824400	Enhancers	Primary monocytes fromperipheralblood	blood
2	chr8:39819800-39823600	Weak transcription	Primary B cells from peripheral blood	blood
3	chr8:39820000-39822000	Flanking Active TSS	GM12878-XiMat	blood
4	chr8:39820000-39822600	Enhancers	Hela-S3	cervix
5	chr8:39820200-39822000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
6	chr8:39820400-39824400	Enhancers	HUVEC	blood vessel
7	chr8:39820800-39827000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
8	chr8:39821000-39822000	Enhancers	A549	lung
9	chr8:39821600-39822000	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
10	chr8:39822000-39822200	Flanking Active TSS	A549	lung
11	chr8:39822000-39822600	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr8:39822000-39822800	Enhancers	GM12878-XiMat	blood
13	chr8:39822000-39824400	Enhancers	Monocytes-CD14+_RO01746	blood
14	chr8:39822200-39822400	Active TSS	A549	lung
15	chr8:39822400-39822600	Flanking Active TSS	A549	lung
16	chr8:39822800-39823200	Weak transcription	GM12878-XiMat	blood
17	chr8:39823200-39824400	Enhancers	GM12878-XiMat	blood
18	chr8:39823600-39824400	Enhancers	Primary B cells from peripheral blood	blood
19	chr8:39824400-39826600	Weak transcription	Monocytes-CD14+_RO01746	blood
20	chr8:39824400-39827000	Weak transcription	Primary monocytes fromperipheralblood	blood
21	chr8:39824400-39827200	Weak transcription	GM12878-XiMat	blood
22	chr8:39824400-39827400	Weak transcription	Primary B cells from peripheral blood	blood
23	chr8:39825800-39826000	Enhancers	Primary T cells from cord blood	blood
24	chr8:39826000-39827200	Weak transcription	Primary T cells from cord blood	blood
25	chr8:39826600-39829200	Enhancers	Monocytes-CD14+_RO01746	blood
26	chr8:39827000-39828200	Enhancers	Primary hematopoietic stem cells short term culture	blood
27	chr8:39827000-39830600	Enhancers	Primary monocytes fromperipheralblood	blood
28	chr8:39827200-39828200	Enhancers	Primary T cells from cord blood	blood
29	chr8:39827200-39828200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
30	chr8:39827400-39827600	Enhancers	GM12878-XiMat	blood
31	chr8:39827400-39828200	Enhancers	Primary B cells from peripheral blood	blood
32	chr8:39828200-39829200	Weak transcription	Primary T cells from cord blood	blood
33	chr8:39828200-39829600	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
34	chr8:39828800-39829200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
35	chr8:39829200-39829400	Enhancers	Primary T cells from cord blood	blood
36	chr8:39829200-39830000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
37	chr8:39829800-39830000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
38	chr8:39830000-39830600	Enhancers	Monocytes-CD14+_RO01746	blood
39	chr8:39835000-39835600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
40	chr8:39835200-39853600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
41	chr8:39835400-39835600	Active TSS	K562	blood
42	chr8:39835600-39835800	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
43	chr8:39835600-39835800	Active TSS	Gastric	stomach
44	chr8:39835600-39835800	Enhancers	Stomach Smooth Muscle	stomach
45	chr8:39835600-39835800	Flanking Active TSS	K562	blood
46	chr8:39835600-39836000	Active TSS	Right Ventricle	heart
47	chr8:39835600-39836200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
48	chr8:39835600-39836200	Enhancers	HUES48 Cell Line	embryonic stem cell
49	chr8:39835600-39836200	Enhancers	HUES6 Cell Line	embryonic stem cell
50	chr8:39835600-39836200	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links